...
首页> 外文期刊>The journal of clinical endocrinology and metabolism >Approach to the Hypophosphatemic Patient
【24h】

Approach to the Hypophosphatemic Patient

机译:低磷血症患者的治疗方法

获取原文
           

摘要

Hypophosphatemia is commonly missed due to nonspecific signs and symptoms, but it causes considerable morbidity and in some cases contributes to mortality. Three primary mechanisms of hypophosphatemia exist: increased renal excretion, decreased intestinal absorption, and shifts from the extracellular to intracellular compartments. Renal hypophosphatemia can be further divided into fibroblast growth factor 23-mediated or non-fibroblast growth factor 23-mediated causes. Proper diagnosis requires a thorough medication history, family history, physical examination, and assessment of renal tubular phosphate handling to identify the cause. During the past decade, our understanding of phosphate metabolism has grown greatly through the study of rare disorders of phosphate homeostasis. Treatment of hypophosphatemia depends on the underlying disorder and requires close biochemical monitoring. This article illustrates an approach to the hypophosphatemic patient and discusses normal phosphate metabolism.
机译:低磷血症通常是由于非特异性的体征和症状而遗漏的,但是它会引起相当大的发病率,并且在某些情况下会导致死亡。存在低磷血症的三个主要机制:肾排泄增加,肠吸收减少以及从细胞外区室转移到细胞内区室。肾性低磷血症可进一步分为成纤维细胞生长因子23介导或非成纤维细胞生长因子23介导的原因。正确的诊断需要彻底的用药史,家族史,体格检查和评估肾小管磷酸盐处理以鉴定病因。在过去的十年中,通过对罕见的磷酸盐体内稳态疾病的研究,我们对磷酸盐代谢的理解有了很大的增长。低磷血症的治疗取决于潜在的疾病,需要密切的生化监测。本文说明了低磷酸盐血症患者的治疗方法,并讨论了正常的磷酸盐代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号